Page last updated: 2024-11-08

serine and Diabetes Mellitus, Type 2

serine has been researched along with Diabetes Mellitus, Type 2 in 87 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"The objective of this clinical study is to examine the association between D-serine and diabetic retinopathy (DR)."7.80Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy. ( Du, J; He, T; Jiang, H; Qu, J; Song, Z; Wu, S, 2014)
"Insulin resistance is a primary characteristic of type 2 diabetes and likely causally related to the pathogenesis of the disease."5.33Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes. ( Danielsson, A; Nystrom, FH; Ost, A; Strålfors, P, 2005)
"The objective of this clinical study is to examine the association between D-serine and diabetic retinopathy (DR)."3.80Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy. ( Du, J; He, T; Jiang, H; Qu, J; Song, Z; Wu, S, 2014)
"Results showed that E2 influenced on protein levels of insulin receptor substrate-1 (IRS-1) and impaired insulin-induced Ser308 phosphorylation of Akt/PKB and Ser9 phosphorylation of GSK3β in Huh7 cells, leading to an inhibition of glucose uptake and glycogen synthesis, respectively, and eventually insulin resistance."3.78Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes. ( Chen, TY; Chiou, HL; Hsieh, MJ; Lan, KP; Lin, YF; Liu, HY; Zhang, XZ, 2012)
"IRS-1 serine phosphorylation is often elevated in insulin resistance models, but confirmation in vivo in humans is lacking."3.77Global IRS-1 phosphorylation analysis in insulin resistance. ( De Filippis, E; Finlayson, J; Langlais, P; Luo, M; Mandarino, LJ; Mapes, R; Mattern, M; Meyer, C; Plummer, E; Tongchinsub, P; Yi, Z, 2011)
"A promising approach for treating type 2 diabetes mellitus (T2DM) is to target the Peroxisome Proliferator-Activated Receptor γ (PPARγ) transcription factor, which regulates the expression of proteins critical for T2DM."2.72The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes. ( Bruning, JB; Frkic, RL; Richter, K, 2021)
"To clarify the role of Gly482Ser in type 2 diabetes and related human metabolic phenotypes we genotyped this polymorphism in a case-control study and performed a meta-analysis of relevant published data."2.43Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. ( Barroso, I; Crowley, V; Franks, PW; Luan, J; O'Rahilly, S; Sandhu, MS; Schafer, AJ; Wareham, NJ, 2006)
"Obesity is linked to the development of major metabolic disorders such as type 2 diabetes, cardiovascular disease, and cancer."1.91Serine Threonine-Protein Kinase-Derived IW13 Improves Lipid Metabolism via C/EBP-α/SREBP1/FAS Signaling Pathways in HFD-Induced Zebrafish In Vivo Larval Model. ( , 2023)
"The diagnosis of diabetic nephropathy (DN), the major cause of ESKD, requires kidney biopsy."1.62Identification of Diabetic Nephropathy in Patients Undergoing Kidney Biopsy through Blood and Urinary Profiles of d-Serine. ( Hayashi, T; Hesaka, A; Horio, M; Ikeda, T; Imamura, R; Isaka, Y; Iwata, Y; Kawamura, M; Kimura, T; Mita, M; Nakane, M; Okushima, H; Takahara, S; Tanaka, Y, 2021)
"Neither the FCH subjects nor the type 2 diabetes patients were found to have the S323I variant."1.37S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetes. ( Chen, BD; Fu, ZY; Li, XM; Liu, F; Ma, X; Ma, YT; Xie, X; Yang, SJ; Yang, YN; Zheng, YY, 2011)
"We conclude that advanced diabetic nephropathy is associated with increased renal H3K9 and H3K23 acetylation, H3K4 dimethylation and H3 phosphorylation at serine 10 that enhance chromatin unfolding and gene expression."1.36Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. ( Anders, HJ; Eulberg, D; Gaikwad, AB; Klussmann, S; Kulkarni, O; Lichtnekert, J; Sayyed, SG; Tikoo, K, 2010)
"We hypothesize that type 1 and type 2 diabetes may contribute to AD through different mechanisms; in type 2 diabetes, hyperglycemia-mediated tau cleavage may be the key feature, whereas insulin deficiency may be the major contributing factor in type 1 diabetes."1.35Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. ( Backus, C; Feldman, EL; Hayes, JM; Kim, B; Oh, S, 2009)
"In db/db mice at 2 weeks of type 2 diabetes, VEGF expression was increased, which was due not to increase in transcription but to augmented translation of VEGF mRNA."1.35PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. ( Feliers, D; Lee, MJ; Mariappan, MM; Sataranatarajan, K, 2008)
"Insulin resistance is a primary characteristic of type 2 diabetes and likely causally related to the pathogenesis of the disease."1.33Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes. ( Danielsson, A; Nystrom, FH; Ost, A; Strålfors, P, 2005)
" We conclude that SNPs in PPARD modify the conversion from IGT to type 2 diabetes, particularly in combination with the SNPs of PGC-1A and PPARG2."1.33Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. ( Andrulionyte, L; Chiasson, JL; Laakso, M; Peltola, P, 2006)
"Insulin resistance was estimated using the homeostasis model assessment (HOMA) index."1.31Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus. ( Groop, L; Klannemark, M; Orho-Melander, M; Suurinkeroinen, L; Taskinen, MR, 2000)
" Finally, glucagon-stimulated insulin secretion by RIN cells expressing the mutant receptor was decreased such that the dose-response curve was shifted to the right in comparison to that obtained with cells expressing the wild type receptor."1.29The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. ( Abrahamsen, N; Froguel, P; Hager, J; Hansen, LH; Jelinek, L; Kindsvogel, W; Nishimura, E, 1996)
"None of the NIDDM or impaired glucose tolerant patients had this polymorphism."1.29Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland. ( Groop, L; Huang, X; Lehto, M; Orho, M, 1995)

Research

Studies (87)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's15 (17.24)18.2507
2000's32 (36.78)29.6817
2010's23 (26.44)24.3611
2020's17 (19.54)2.80

Authors

AuthorsStudies
Iwata, Y1
Okushima, H1
Hesaka, A1
Kawamura, M1
Imamura, R1
Takahara, S1
Horio, M1
Tanaka, Y1
Ikeda, T1
Nakane, M1
Mita, M1
Hayashi, T1
Isaka, Y1
Kimura, T1
Liu, Y2
Liu, B1
Qiao, YC1
Niu, WY1
Zhang, H2
Dong, M1
Yuan, S1
Jin, W1
Li, H1
Song, D1
Liu, Q1
Li, L1
Sun, X1
Guo, J1
Li, D1
Li, P1
Alka, K1
Mohammad, G1
Kowluru, RA1
Yu, M1
Sun, Y1
Shan, X1
Yang, F1
Chu, G1
Chen, Q1
Han, L1
Guo, Z1
Wang, G1
Sakaguchi, M1
Okagawa, S1
Okubo, Y1
Otsuka, Y1
Fukuda, K1
Igata, M1
Kondo, T1
Sato, Y1
Yoshizawa, T1
Fukuda, T1
Yamagata, K3
Cai, W1
Tseng, YH1
Sakaguchi, N1
Kahn, CR1
Araki, E1
Holeček, M1
Lallement, J1
Raho, I1
Merlen, G1
Rainteau, D1
Croyal, M1
Schiffano, M1
Kassis, N1
Doignon, I1
Soty, M1
Lachkar, F1
Krempf, M1
Van Hul, M1
Cani, PD1
Foufelle, F1
Amouyal, C1
Le Stunff, H1
Magnan, C1
Tordjmann, T1
Cruciani-Guglielmacci, C1
Keller, LJ1
Nguyen, TH1
Liu, LJ1
Hurysz, BM1
Lakemeyer, M1
Guerra, M1
Gelsinger, DJ1
Chanin, R1
Ngo, N1
Lum, KM1
Faucher, F1
Ipock, P1
Niphakis, MJ1
Bhatt, AS1
O'Donoghue, AJ1
Huang, KC1
Bogyo, M1
Wang, W1
Tanokashira, D1
Fukui, Y1
Maruyama, M1
Kuroiwa, C1
Saito, T1
Saido, TC1
Taguchi, A1
Liu, PJ1
Yao, A1
Chen, XY1
Ma, L1
Hou, YX1
Bonelli, R3
Woods, SM1
Ansell, BRE2
Heeren, TFC1
Egan, CA1
Khan, KN1
Guymer, R1
Trombley, J1
Friedlander, M1
Bahlo, M3
Fruttiger, M1
Lotta, LA1
Pietzner, M1
Stewart, ID1
Wittemans, LBL1
Li, C1
Raffler, J1
Biggs, EK1
Oliver-Williams, C1
Auyeung, VPW1
Luan, J2
Wheeler, E1
Paige, E1
Surendran, P1
Michelotti, GA1
Scott, RA1
Burgess, S1
Zuber, V1
Sanderson, E1
Koulman, A1
Imamura, F1
Forouhi, NG1
Khaw, KT1
Griffin, JL1
Wood, AM1
Kastenmüller, G1
Danesh, J1
Butterworth, AS1
Gribble, FM1
Reimann, F1
Fauman, E1
Wareham, NJ2
Langenberg, C2
Fridman, V1
Zarini, S1
Sillau, S1
Harrison, K1
Bergman, BC1
Feldman, EL2
Reusch, JEB1
Callaghan, BC1
Lotta, L1
Scerri, T1
Clemons, TE1
Leung, I1
Peto, T1
Bird, AC1
Sallo, FB1
Frkic, RL1
Richter, K1
Bruning, JB1
Vandenbeek, R1
Khan, NP1
Estall, JL1
Okuyama, S1
Shinoka, W1
Nakamura, K1
Kotani, M1
Sawamoto, A1
Sugawara, K1
Sudo, M1
Nakajima, M1
Furukawa, Y1
Bathina, S1
Das, UN1
Holm, LJ1
Buschard, K1
Shibata, T1
Takaguri, A1
Ichihara, K1
Satoh, K1
Thewissen, MM1
van de Gaar, J1
den Boer, AT1
Munsters, MJ1
Blaak, EE1
Duijvestijn, A1
Jiang, H1
Du, J1
He, T1
Qu, J1
Song, Z1
Wu, S1
Li, J1
Bi, L1
Hulke, M1
Li, T1
Xie, X2
Zhou, X1
Chen, W1
Long, L1
Li, W1
Yang, X1
Li, S1
Wang, L3
Pichu, S1
Sathiyamoorthy, J1
Krishnamoorthy, E1
Umapathy, D1
Viswanathan, V1
Simon-Szabó, L1
Kokas, M1
Greff, Z1
Boros, S1
Bánhegyi, P1
Zsákai, L1
Szántai-Kis, C1
Vantus, T1
Mandl, J1
Bánhegyi, G1
Vályi-Nagy, I1
Őrfi, L1
Ullrich, A1
Csala, M1
Kéri, G1
Nystoriak, MA1
Nieves-Cintrón, M1
Patriarchi, T1
Buonarati, OR1
Prada, MP1
Morotti, S1
Grandi, E1
Fernandes, JD1
Forbush, K1
Hofmann, F1
Sasse, KC1
Scott, JD1
Ward, SM1
Hell, JW1
Navedo, MF1
Okauchi, Y1
Iwahashi, H1
Okita, K1
Yuan, M1
Matsuda, M1
Tanaka, T1
Miyagawa, J1
Funahashi, T1
Horikawa, Y1
Shimomura, I1
Qu, Y1
Yang, Z1
Jin, F1
Sun, L1
Zhang, C2
Ji, L1
Sun, H1
Wang, B1
Sparks, SM1
Banker, P1
Bickett, DM1
Clancy, DC1
Dickerson, SH1
Garrido, DM1
Golden, PL1
Peat, AJ1
Sheckler, LR1
Tavares, FX1
Thomson, SA1
Weiel, JE1
Daimon, M1
Oizumi, T1
Toriyama, S1
Karasawa, S1
Jimbu, Y1
Wada, K1
Kameda, W1
Susa, S1
Muramatsu, M1
Kubota, I1
Kawata, S1
Kato, T1
Zhang, HM1
Chen, LL1
Liao, YF1
Wu, ZH1
Ye, F1
Xu, S1
Yi, LL1
Yang, J1
Park, Y1
Gao, X1
Wilson, E1
Zimmer, W1
Abbott, L1
Kim, B1
Backus, C1
Oh, S1
Hayes, JM1
Liu, S1
Okada, T1
Assmann, A1
Soto, J1
Liew, CW1
Bugger, H1
Shirihai, OS1
Abel, ED1
Kulkarni, RN1
Király, MA1
Campbell, J1
Park, E1
Bates, HE1
Yue, JT1
Rao, V1
Matthews, SG1
Bikopoulos, G1
Rozakis-Adcock, M1
Giacca, A1
Vranic, M1
Riddell, MC1
Sayyed, SG1
Gaikwad, AB1
Lichtnekert, J1
Kulkarni, O1
Eulberg, D1
Klussmann, S1
Tikoo, K1
Anders, HJ1
Bertea, M1
Rütti, MF1
Othman, A1
Marti-Jaun, J1
Hersberger, M1
von Eckardstein, A1
Hornemann, T1
Langlais, P1
Yi, Z1
Finlayson, J1
Luo, M1
Mapes, R1
De Filippis, E1
Meyer, C1
Plummer, E1
Tongchinsub, P1
Mattern, M1
Mandarino, LJ1
Fatehi, M1
Raja, M1
Carter, C1
Soliman, D1
Holt, A1
Light, PE1
Zheng, YY1
Ma, YT1
Yang, YN1
Fu, ZY1
Li, XM1
Liu, F1
Yang, SJ1
Ma, X1
Chen, BD1
Vind, BF1
Birk, JB1
Vienberg, SG1
Andersen, B1
Beck-Nielsen, H1
Wojtaszewski, JF1
Højlund, K1
Hsieh, MJ1
Lan, KP1
Liu, HY1
Zhang, XZ1
Lin, YF1
Chen, TY1
Chiou, HL1
Tokuda, H1
Kato, K1
Kasahara, S1
Matsushima-Nishiwaki, R1
Mizuno, T1
Sakakibara, S1
Kozawa, O1
Xie, W1
Wood, AR1
Lyssenko, V1
Weedon, MN1
Knowles, JW1
Alkayyali, S1
Assimes, TL1
Quertermous, T1
Abbasi, F1
Paananen, J1
Häring, H1
Hansen, T3
Pedersen, O4
Smith, U1
Laakso, M3
Dekker, JM1
Nolan, JJ1
Groop, L3
Ferrannini, E1
Adam, KP1
Gall, WE1
Frayling, TM1
Walker, M1
Muller, YL1
Bogardus, C1
Baier, L1
Cho, YM1
Kim, M1
Park, KS1
Kim, SY1
Lee, HK1
Bouzakri, K1
Roques, M1
Gual, P1
Espinosa, S1
Guebre-Egziabher, F1
Riou, JP1
Laville, M1
Le Marchand-Brustel, Y1
Tanti, JF1
Vidal, H1
Schmitz-Peiffer, C1
Whitehead, JP1
Fehmann, HC1
Gross, U1
Epe, M1
Hartman, ME1
O'Connor, JC1
Godbout, JP1
Minor, KD1
Mazzocco, VR1
Freund, GG1
Kunej, T1
Globocnik Petrovic, M1
Dovc, P1
Peterlin, B1
Petrovic, D1
Sanke, T1
Sakagashira, S1
Danielsson, A1
Ost, A1
Nystrom, FH1
Strålfors, P1
Yao, K1
Xu, B1
Gao, L1
Ge, JB1
Morino, K1
Petersen, KF1
Dufour, S1
Befroy, D1
Frattini, J1
Shatzkes, N1
Neschen, S1
White, MF1
Bilz, S1
Sono, S1
Pypaert, M1
Shulman, GI1
Tzatsos, A1
Kandror, KV1
Barroso, I1
Sandhu, MS1
Franks, PW1
Crowley, V1
Schafer, AJ1
O'Rahilly, S1
Radha, V1
Mohan, V1
Vidya, R1
Ashok, AK1
Deepa, R1
Mathias, RA1
Hu, Y1
Liu, W1
Huang, R1
Zhang, X1
Andrulionyte, L1
Peltola, P1
Chiasson, JL1
Gao, JX1
Xu, DL1
Shao, YH1
Lao, WY1
Lin, S1
Zhang, B1
Sataranatarajan, K1
Lee, MJ1
Mariappan, MM1
Feliers, D1
Fujisawa, T1
Ikegami, H1
Yamato, E1
Takekawa, K1
Nakagawa, Y1
Hamada, Y1
Ueda, H1
Fukuda, M1
Ogihara, T1
Kellerer, M1
Coghlan, M1
Capp, E1
Mühlhöfer, A1
Kroder, G1
Mosthaf, L1
Galante, P1
Siddle, K1
Häring, HU1
Orho, M2
Nikula-Ijäs, P1
Schalin-Jäntti, C1
Permutt, MA1
Groop, LC1
Hua, QX1
Shoelson, SE1
Inouye, K1
Weiss, MA1
Hansen, LH1
Abrahamsen, N1
Hager, J1
Jelinek, L1
Kindsvogel, W1
Froguel, P2
Nishimura, E1
Huang, X1
Lehto, M1
Hart, LM1
Stolk, RP1
Jansen, JJ1
Grobbee, DE1
Lemkes, HH1
Maassen, JA1
Odawara, M2
Matsunuma, A1
Yamashita, K2
Tachi, Y1
Arai, K1
Kajimoto, Y1
Yamasaki, Y1
Urhammer, SA1
Møller, AM1
Nyholm, B1
Ekstrøm, CT1
Eiberg, H1
Clausen, JO1
Schmitz, O1
Boutin, P1
Gresh, L1
Cisse, A1
Hara, M1
Bell, G1
Babu, S1
Eisenbarth, G1
Liu, L1
Xiang, K1
Mammarella, S1
Creati, B1
Esposito, DL1
Arcuri, P1
Della Loggia, F1
Capani, F1
Mariani-Costantini, R1
Caramia, FG1
Battista, P1
Cama, A1
Ambrosch, A1
Lobmann, R1
Dierkes, J1
König, W1
Luley, C1
Lehnert, H1
Pulkkinen, A1
Viitanen, L1
Kareinen, A1
Lehto, S1
Hayakawa, T1
Nagai, Y1
Ando, H1
Yamashita, H1
Takamura, T1
Abe, T1
Nomura, G1
Kobayashi, KI1
Klannemark, M1
Suurinkeroinen, L1
Orho-Melander, M1
Taskinen, MR1
Frame, S1
Cohen, P1
Biondi, RM1
Echwald, SM1
Bach, H1
Vestergaard, H1
Richelsen, B1
Kristensen, K1
Drivsholm, T1
Borch-Johnsen, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in Pulmonary Arterial Hypertension[NCT03979482]30 participants (Actual)Observational2019-06-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for serine and Diabetes Mellitus, Type 2

ArticleYear
Role of Impaired Glycolysis in Perturbations of Amino Acid Metabolism in Diabetes Mellitus.
    International journal of molecular sciences, 2023, Jan-15, Volume: 24, Issue:2

    Topics: Amino Acids; Amino Acids, Branched-Chain; Diabetes Mellitus, Type 2; Glycine; Glycolysis; Humans; Py

2023
The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes.
    The Journal of biological chemistry, 2021, Volume: 297, Issue:3

    Topics: Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Ligands; Phosphorylation; PPAR gamma; Protein

2021
Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
    Endocrinology, 2018, 02-01, Volume: 159, Issue:2

    Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Genetic Linkage; Genetic Predisposition to Disea

2018
L-serine: a neglected amino acid with a potential therapeutic role in diabetes.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2019, Volume: 127, Issue:10

    Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supple

2019
IRS-1 regulation in health and disease.
    IUBMB life, 2003, Volume: 55, Issue:7

    Topics: Animals; Cysteine Endopeptidases; Diabetes Mellitus, Type 2; Gene Expression Regulation; Humans; Ins

2003
[S20G mutation of amylin gene--amyloid diabetes due to S20G amylin gene mutation].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 2

    Topics: Amino Acid Sequence; Amino Acid Substitution; Amyloid; Animals; Diabetes Mellitus, Type 2; Genetic P

2005
[HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 2

    Topics: Amino Acid Substitution; Canada; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Genetic Predisposi

2005
Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
    Diabetologia, 2006, Volume: 49, Issue:3

    Topics: Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Glycine; Heat-Shock Proteins; Hu

2006
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
    Journal of lipid research, 2006, Volume: 47, Issue:9

    Topics: Amino Acid Substitution; Asparagine; Coronary Disease; Diabetes Mellitus, Type 2; Dyslipidemias; Hum

2006

Trials

1 trial available for serine and Diabetes Mellitus, Type 2

ArticleYear
Rarity of the Asn291Ser mutation of lipoprotein lipase gene in Japanese NIDDM patients.
    Diabetes research and clinical practice, 1997, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asparagine; Diabetes Mellitus, Type 2; Female; Gene Freq

1997

Other Studies

77 other studies available for serine and Diabetes Mellitus, Type 2

ArticleYear
Identification of Diabetic Nephropathy in Patients Undergoing Kidney Biopsy through Blood and Urinary Profiles of d-Serine.
    Kidney360, 2021, 11-25, Volume: 2, Issue:11

    Topics: Biopsy; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Serine

2021
A New Case of Hb Headington (
    Hemoglobin, 2022, Volume: 46, Issue:3

    Topics: Aged; Arginine; beta-Globins; Diabetes Mellitus, Type 2; DNA; Female; Glycated Hemoglobin; Hemoglobi

2022
Oral glucagon-like peptide 1 analogue ameliorates glucose intolerance in db/db mice.
    Biotechnology letters, 2022, Volume: 44, Issue:10

    Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glucagon-Like Pe

2022
miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
    Molecular medicine (Cambridge, Mass.), 2022, 09-30, Volume: 28, Issue:1

    Topics: Animals; Atherosclerosis; Azo Compounds; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus, Ex

2022
Regulation of serine palmitoyl-transferase and Rac1-Nox2 signaling in diabetic retinopathy.
    Scientific reports, 2022, 10-06, Volume: 12, Issue:1

    Topics: Animals; Ceramides; Cytosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic R

2022
Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
    Cellular & molecular biology letters, 2022, Oct-08, Volume: 27, Issue:1

    Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glucose; Glutathione; Malo

2022
Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling.
    Nature communications, 2022, 10-14, Volume: 13, Issue:1

    Topics: Adipocytes; Animals; Diabetes Mellitus, Type 2; Homeostasis; Insulin; Insulin Resistance; Male; Mice

2022
Serine Threonine-Protein Kinase-Derived IW13 Improves Lipid Metabolism via C/EBP-α/SREBP1/FAS Signaling Pathways in HFD-Induced Zebrafish In Vivo Larval Model.
    Applied biochemistry and biotechnology, 2023, Volume: 195, Issue:8

    Topics: Animals; Antioxidants; CCAAT-Enhancer-Binding Protein-alpha; Diabetes Mellitus, Type 2; Lipid Metabo

2023
Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2023, Volume: 1868, Issue:8

    Topics: Animals; Bile Acids and Salts; Ceramides; Diabetes Mellitus, Type 2; Glucose; Homeostasis; Liver; Mi

2023
Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicron.
    Nature chemical biology, 2023, Volume: 19, Issue:12

    Topics: Bacteroides thetaiotaomicron; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Humans; Serine

2023
Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD.
    Nutrients, 2019, Aug-17, Volume: 11, Issue:8

    Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Dia

2019
Associations of TMPRSS6 Polymorphisms with Gestational Diabetes Mellitus in Chinese Han Pregnant Women: a Preliminary Cohort Study.
    Biological trace element research, 2021, Volume: 199, Issue:2

    Topics: China; Cohort Studies; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Membrane Pr

2021
Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease.
    Scientific reports, 2020, 07-22, Volume: 10, Issue:1

    Topics: Aged; Carbamoyl-Phosphate Synthase (Ammonia); Case-Control Studies; Diabetes Mellitus, Type 2; Femal

2020
A cross-platform approach identifies genetic regulators of human metabolism and health.
    Nature genetics, 2021, Volume: 53, Issue:1

    Topics: Diabetes Mellitus, Type 2; Eye Diseases; Gene Frequency; Genetic Loci; Genetic Pleiotropy; Genome, H

2021
Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity.
    Journal of diabetes and its complications, 2021, Volume: 35, Issue:4

    Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Obesity; Serine; Tandem Mass Spectrometry

2021
Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.
    Genome medicine, 2021, 03-09, Volume: 13, Issue:1

    Topics: Biosynthetic Pathways; Diabetes Mellitus, Type 2; Disease Progression; Endophenotypes; Genetic Loci;

2021
Suppressive effects of the peel of Citrus kawachiensis (Kawachi Bankan) on astroglial activation, tau phosphorylation, and inhibition of neurogenesis in the hippocampus of type 2 diabetic db/db mice.
    Bioscience, biotechnology, and biochemistry, 2018, Volume: 82, Issue:8

    Topics: Animals; Blood Glucose; Citrus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hippocam

2018
Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats.
    Lipids in health and disease, 2018, Jul-24, Volume: 17, Issue:1

    Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Diabetes Mellitus, Experimental; Diabe

2018
Inhibition of the TNF-α-induced serine phosphorylation of IRS-1 at 636/639 by AICAR.
    Journal of pharmacological sciences, 2013, Volume: 122, Issue:2

    Topics: 3T3-L1 Cells; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cells, Cultured; D

2013
Monocytes, but not T cells, respond to insulin with Akt(S473) phosphorylation independent of the donor glucometabolic state.
    Diabetes/metabolism research and reviews, 2014, Volume: 30, Issue:4

    Topics: Aged; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 2; Female; Glu

2014
Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
    Clinical & experimental ophthalmology, 2014, Volume: 42, Issue:9

    Topics: Aged; Aqueous Humor; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes Mellitus,

2014
Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.
    The Journal of biological chemistry, 2014, Aug-08, Volume: 289, Issue:32

    Topics: Adaptor Proteins, Vesicular Transport; Animals; Diabetes Mellitus, Type 2; Diet, Western; Fenofibrat

2014
L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation.
    Biochimica et biophysica acta, 2015, Volume: 1850, Issue:1

    Topics: 3T3-L1 Cells; Adipose Tissue, White; Animals; Binding, Competitive; Blotting, Western; Cyclin-Depend

2015
Impact of the hypoxia inducible factor-1α (HIF-1α) pro582ser polymorphism and its gene expression on diabetic foot ulcers.
    Diabetes research and clinical practice, 2015, Volume: 109, Issue:3

    Topics: Adult; Aged; Amino Acid Substitution; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot

2015
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.
    Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2

    Topics: Diabetes Mellitus, Type 2; HEK293 Cells; Humans; Hypoglycemic Agents; Insulin Receptor Substrate Pro

2016
Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.
    Science signaling, 2017, 01-24, Volume: 10, Issue:463

    Topics: Acute Disease; Adult; Aged; Animals; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases;

2017
PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men.
    Endocrine journal, 2008, Volume: 55, Issue:6

    Topics: Adiponectin; Aged; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glycine; Heat-Shock Proteins;

2008
The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese.
    Journal of genetics, 2008, Volume: 87, Issue:2

    Topics: Amino Acid Substitution; Aryldialkylphosphatase; Asian People; Blood Pressure; Case-Control Studies;

2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
    Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cytochrom

2009
Association of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM.
    Biochemical and biophysical research communications, 2009, Aug-14, Volume: 386, Issue:1

    Topics: Aged; Amino Acid Substitution; Asian People; Cysteine; Diabetes Mellitus, Type 2; DNA Glycosylases;

2009
Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.
    Journal of endocrinological investigation, 2009, Volume: 32, Issue:3

    Topics: Adult; Aged; Amino Acid Substitution; Case-Control Studies; China; Diabetes Mellitus, Type 2; Diabet

2009
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:4

    Topics: Animals; Arterioles; Biomarkers; Chemokine CCL2; Coronary Vessels; Diabetes Mellitus, Type 2; Diabet

2009
Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.
    Endocrinology, 2009, Volume: 150, Issue:12

    Topics: Age Factors; Animals; Blood Glucose; Brain; Cerebral Cortex; Diabetes Mellitus, Type 1; Diabetes Mel

2009
Insulin signaling regulates mitochondrial function in pancreatic beta-cells.
    PloS one, 2009, Nov-24, Volume: 4, Issue:11

    Topics: Animals; Cyclic AMP-Dependent Protein Kinases; Cytosol; Diabetes Mellitus, Type 2; Glucokinase; Huma

2009
Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats.
    American journal of physiology. Endocrinology and metabolism, 2010, Volume: 298, Issue:3

    Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Exercise Therapy; Glu

2010
Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:6

    Topics: Acetylation; Animals; Base Sequence; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathi

2010
Deoxysphingoid bases as plasma markers in diabetes mellitus.
    Lipids in health and disease, 2010, Aug-16, Volume: 9

    Topics: Aged; Alanine; Biomarkers; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabeti

2010
Global IRS-1 phosphorylation analysis in insulin resistance.
    Diabetologia, 2011, Volume: 54, Issue:11

    Topics: Adult; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic

2011
The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.
    Diabetes, 2012, Volume: 61, Issue:1

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Alanine; Amino Acid Substitution; ATP-Binding Cas

2012
S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetes.
    Genetics and molecular research : GMR, 2011, Dec-22, Volume: 10, Issue:4

    Topics: Adult; Aged; Alleles; Asian People; Cardiovascular Diseases; Case-Control Studies; China; Diabetes M

2011
Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
    Diabetologia, 2012, Volume: 55, Issue:5

    Topics: Diabetes Mellitus, Type 2; Female; Glucose; Glucose Clamp Technique; Glycogen Synthase; Humans; Hype

2012
Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes.
    BMC gastroenterology, 2012, Jun-21, Volume: 12

    Topics: Cell Line; Diabetes Mellitus, Type 2; Glucose; Glycogen; Glycogen Synthase Kinase 3; Glycogen Syntha

2012
Significant correlation between the acceleration of platelet aggregation and phosphorylation of HSP27 at Ser-78 in diabetic patients.
    International journal of molecular medicine, 2012, Volume: 30, Issue:6

    Topics: Adenosine Diphosphate; Aged; Blood Platelets; Case-Control Studies; CD40 Ligand; Diabetes Mellitus,

2012
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes.
    Diabetes, 2013, Volume: 62, Issue:6

    Topics: Adult; Betaine; Diabetes Mellitus, Type 2; Female; Glycine; Humans; Insulin Resistance; Male; Middle

2013
A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: Adipocytes; Adipose Tissue; Adult; Alleles; Blood Glucose; Body Composition; Body Mass Index; Cell S

2003
S20G mutation of the amylin gene is associated with a lower body mass index in Korean type 2 diabetic patients.
    Diabetes research and clinical practice, 2003, Volume: 60, Issue:2

    Topics: Age of Onset; Amino Acid Substitution; Amyloid; Asian People; Body Mass Index; Diabetes Mellitus, Ty

2003
Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.
    Diabetes, 2003, Volume: 52, Issue:6

    Topics: Biopsy; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression Regulation, Enzymologic; Hexokin

2003
A new mutation in the hepatocyte nuclear factor-1-alpha gene (P224S) in a newly discovered German family with maturity-onset diabetes of the young 3 (MODY 3). Family members carry additionally the homozygous I27L amino acid polymorphism in the HNF1 alpha
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2004, Volume: 112, Issue:2

    Topics: Adolescent; Aged; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Exons; Female; Hepatocyte Nuclear

2004
Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.
    The Journal of biological chemistry, 2004, Jul-02, Volume: 279, Issue:27

    Topics: Amino Acid Motifs; Animals; Blood Glucose; Blotting, Western; Cell Line; Diabetes Mellitus, Type 2;

2004
A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians.
    Folia biologica, 2004, Volume: 50, Issue:5

    Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to D

2004
Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes.
    The Journal of biological chemistry, 2005, Oct-14, Volume: 280, Issue:41

    Topics: Adipocytes; Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Electrophoresis, Gel,

2005
Pravastatin activates platelet nitric oxide synthase (NOS) in patients with type 2 diabetes mellitus and NOS activation is accompanied by serine phosphorylation.
    Chinese medical journal, 2005, Oct-05, Volume: 118, Issue:19

    Topics: Blood Platelets; Diabetes Mellitus, Type 2; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Red

2005
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
    The Journal of clinical investigation, 2005, Volume: 115, Issue:12

    Topics: Biopsy; Blood Glucose; Blotting, Western; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; D

2005
Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
    Molecular and cellular biology, 2006, Volume: 26, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Glucose;

2006
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
    The American journal of cardiology, 2006, May-01, Volume: 97, Issue:9

    Topics: Asian People; Cholesterol, HDL; Deoxyribonuclease HindIII; Diabetes Mellitus, Type 2; Dyslipidemias;

2006
Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Diabetes, 2006, Volume: 55, Issue:7

    Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucose Intolerance

2006
[Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007, Volume: 27, Issue:2

    Topics: Aged; Amino Acid Substitution; Asian People; China; Diabetes Mellitus, Type 2; Female; Gene Frequenc

2007
PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K.
    Cellular signalling, 2008, Volume: 20, Issue:5

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nep

2008
A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus.
    Diabetologia, 1995, Volume: 38, Issue:8

    Topics: Adolescent; Adult; Age of Onset; Aged; Diabetes Mellitus, Type 2; France; Genetic Linkage; Glycine;

1995
Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Middle Aged

1995
Isolation and characterization of the human muscle glycogen synthase gene.
    Diabetes, 1995, Volume: 44, Issue:9

    Topics: Adult; Amino Acid Sequence; Animals; Base Sequence; Deoxyribonucleases, Type II Site-Specific; Diabe

1995
Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Jan-15, Volume: 90, Issue:2

    Topics: Amino Acid Sequence; Diabetes Mellitus, Type 2; Humans; Insulin; Magnetic Resonance Spectroscopy; Mo

1993
The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
    Diabetes, 1996, Volume: 45, Issue:6

    Topics: Amino Acid Sequence; Animals; Cell Line; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Exons; G

1996
Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
    Diabetologia, 1995, Volume: 38, Issue:10

    Topics: Alleles; Amino Acid Sequence; Base Sequence; Diabetes Mellitus, Type 2; DNA Primers; Finland; France

1995
Absence of the Gly40-Ser mutation in the glucagon receptor among diabetic patients in the Netherlands.
    Diabetes care, 1995, Volume: 18, Issue:10

    Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gene Frequency; Glycine;

1995
Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
    Diabetes care, 1996, Volume: 19, Issue:5

    Topics: Base Sequence; Codon; Diabetes Mellitus, Type 2; DNA Primers; Female; Glycine; Humans; Japan; Male;

1996
Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
    Human genetics, 1996, Volume: 98, Issue:6

    Topics: Adult; Aged; Asian People; Codon; Diabetes Mellitus, Type 2; Exons; Female; Glucose Intolerance; Gly

1996
The effect of two frequent amino acid variants of the hepatocyte nuclear factor-1alpha gene on estimates of the pancreatic beta-cell function in Caucasian glucose-tolerant first-degree relatives of type 2 diabetic patients.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:11

    Topics: Adult; Amino Acid Substitution; Asparagine; C-Peptide; Diabetes Mellitus, Type 2; DNA-Binding Protei

1998
Missense mutation Gly574Ser in the transcription factor HNF-1alpha is a marker of atypical diabetes mellitus in African-American children.
    Diabetologia, 1999, Volume: 42, Issue:3

    Topics: Adult; Amino Acid Substitution; Black People; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, T

1999
RAGE Gly82Ser polymorphism in diabetic microangiopathy.
    Diabetes care, 1999, Volume: 22, Issue:4

    Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Gene Frequency; Genotype;

1999
Novel allele of the insulin receptor substrate-1 bearing two non-conservative amino acid substitutions in a patient with noninsulin-dependent diabetes mellitus. Mutations in brief no. 130. Online.
    Human mutation, 1998, Volume: 11, Issue:5

    Topics: Alleles; Amino Acid Substitution; Diabetes Mellitus, Type 2; Humans; Insulin Receptor Substrate Prot

1998
Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
    Clinical chemistry and laboratory medicine, 1999, Volume: 37, Issue:7

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Europe; Gene Frequency; Germany; Glycine; Humans; Japan; Mid

1999
Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:6

    Topics: Amino Acid Substitution; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female;

2000
S20G mutation of the amylin gene in Japanese patients with type 2 diabetes.
    Diabetes research and clinical practice, 2000, Volume: 49, Issue:2-3

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amyloid; Asian People; Blood Glucose; Diabe

2000
Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:8

    Topics: Aged; Amino Acid Substitution; Apolipoproteins; Asparagine; Blood Pressure; Cholesterol; Cholesterol

2000
A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.
    Molecular cell, 2001, Volume: 7, Issue:6

    Topics: Amino Acid Sequence; Arginine; Axin Protein; beta Catenin; Binding Sites; Calcium-Calmodulin-Depende

2001
A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro.
    Diabetes, 2002, Volume: 51, Issue:1

    Topics: Amino Acid Substitution; Animals; Diabetes Mellitus, Type 2; Female; Genetic Variation; Genotype; Hu

2002